Obstructive Sleep Apnea Pipeline, Therapeutics Assessment, Clinical Trials, Drugs, and Companies 2024

DelveInsight's, "Obstructive Sleep Apnea Pipeline Insight 2024" report provides comprehensive insights about 20+ companies and 21+ pipeline drugs in Obstructive Sleep Apnea (OSA) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Discover the latest drugs and treatment options in the Obstructive Sleep Apnea Pipeline. Dive into DelveInsight's comprehensive report today! @ Obstructive Sleep Apnea Pipeline Outlook- https://www.delveinsight.com/sample-request/obstructive-sleep-apnea-osa-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Key Takeaways from the Obstructive Sleep Apnea Pipeline Report
• In November 2024:- Eli Lilly and Company- The purpose of this study is to is to evaluate the efficacy and safety of retatrutide in participants with type 2 diabetes in participants who have obesity or overweight (J1I-MC-GZBK master protocol) including a subset of participants who have obstructive sleep apnea (OSA) (J1I-MC-GSA2). The study will last about 89 weeks and will include up to 24 visits.
• DelveInsight's Obstructive Sleep Apnea pipeline report depicts a robust space with 20+ active players working to develop 21+ pipeline therapies for Obstructive Sleep Apnea treatment.
• The leading Obstructive Sleep Apnea Companies such as Apnimed, Therapix Biosciences, Eisai, Idorsia Pharmaceuticals, Takeda, Merck & Co, Taisho Pharmaceutical Co., Ltd., Bayer, Janssen Pharmaceuticals, RespireRx Pharmaceuticals, Cortex Pharmaceuticals, Michael James Enterprises, and others.
• Promising Obstructive Sleep Apnea Pipeline Therapies such as AL539 (SRETT), Lemborexant 10 mg, Sulthiame, Eszopiclone, AD182, AD504, Atomoxetine, and others.

Stay ahead with the most recent pipeline outlook for Obstructive Sleep Apnea. Get insights into clinical trials, emerging therapies, and leading companies with DelveInsight @ Obstructive Sleep Apnea Treatment Drugs- https://www.delveinsight.com/sample-request/obstructive-sleep-apnea-osa-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Obstructive Sleep Apnea Emerging Drugs
• Tirzepatide: Eli Lilly and Company
Tirzepatide is a once-weekly GIP (glucose-dependent insulinotropic polypeptide) receptor and GLP-1 (glucagon-like peptide-1) receptor agonist. Tirzepatide is a single novel molecule that activates the body's receptors for GIP and GLP-1, which are natural incretin hormones. GIP is a hormone that may complement the effects of GLP-1 receptor agonists. In preclinical models, GIP has been shown to decrease food intake and increase energy expenditure therefore resulting in weight reductions, and when combined with GLP-1 receptor agonism, may result in greater effects on markers of metabolic dysregulation such as body weight, glucose and lipids. Currently, the drug is in the Phase III stage of clinical trial evaluation for the treatment of Obstructive Sleep Apnea (OSA).

• Sulthiame: Desitin Arzneimittel GmbH
Sulthiame is an investigational drug being developed by Desitin Arzneimittel GmbH. The drug is a carbonic anhydrase inhibitor, demonstrating a significant efficacy in reducing apneas during sleep. The drug is currently being evaluated under Phase II clinical trial for the treatment of patients with Obstructive sleep apnea.

• GAL-475: Neurim Pharmaceuticals
GAL-475 is a novel therapeutic agent for the treatment of sleep apnea syndromes. The primary site of action for GAL-475 appears to be at the level of the carotid body, a peripheral polymodal chemosensory organ, located at the carotid bifurcation, responsible for sensing changes in partial pressures of O2, CO2 or pH, and activating the brainstem respiratory center to produce hyperventilation. The drug is currently being evaluated under Phase I clinical trial for the treatment of patients with Obstructive Sleep Apnea (OSA).

Explore groundbreaking therapies and clinical trials in the Obstructive Sleep Apnea Pipeline. Access DelveInsight's detailed report now! @ New Obstructive Sleep Apnea Drugs- https://www.delveinsight.com/sample-request/obstructive-sleep-apnea-osa-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Obstructive Sleep Apnea Companies
Apnimed, Therapix Biosciences, Eisai, Idorsia Pharmaceuticals, Takeda, Merck & Co, Taisho Pharmaceutical Co., Ltd., Bayer, Janssen Pharmaceuticals, RespireRx Pharmaceuticals, Cortex Pharmaceuticals, Michael James Enterprises, and others.

Obstructive Sleep Apnea pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Intravenous
• Subcutaneous
• Oral
• Intramuscular

Obstructive Sleep Apnea Products have been categorized under various Molecule types such as
• Monoclonal antibody
• Small molecule
• Peptide

Unveil the future of Obstructive Sleep Apnea Treatment. Learn about new drugs, pipeline developments, and key companies with DelveInsight's expert analysis @ Obstructive Sleep Apnea Market Drivers and Barriers- https://www.delveinsight.com/sample-request/obstructive-sleep-apnea-osa-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Scope of the Obstructive Sleep Apnea Pipeline Report
• Coverage- Global
• Obstructive Sleep Apnea Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
• Obstructive Sleep Apnea Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
• Obstructive Sleep Apnea Companies- Apnimed, Therapix Biosciences, Eisai, Idorsia Pharmaceuticals, Takeda, Merck & Co, Taisho Pharmaceutical Co., Ltd., Bayer, Janssen Pharmaceuticals, RespireRx Pharmaceuticals, Cortex Pharmaceuticals, Michael James Enterprises, and others.
• Obstructive Sleep Apnea Pipeline Therapies- AL539 (SRETT), Lemborexant 10 mg, Sulthiame, Eszopiclone, AD182, AD504, Atomoxetine, and others.

Get the latest on Obstructive Sleep Apnea Therapies and clinical trials. Download DelveInsight's in-depth pipeline report today! @ Obstructive Sleep Apnea Companies, Key Products and Unmet Needs- https://www.delveinsight.com/sample-request/obstructive-sleep-apnea-osa-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1. Introduction
2. Executive Summary
3. Obstructive Sleep Apnea: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. Obstructive Sleep Apnea (OSA)- DelveInsight's Analytical Perspective
7. Late Stage Products (Phase III)
8. Tirzepatide: Eli Lilly and Company
9. Drug profiles in the detailed report…..
10. Mid Stage Products (Phase II)
11. Sulthiame: Desitin Arzneimittel GmbH
12. Drug profiles in the detailed report…..
13. Early Stage Products (Phase I)
14. GAL-475: Neurim Pharmaceuticals
15. Drug profiles in the detailed report…..
16. Preclinical and Discovery Stage Products
17. Drug name: Company name
18. Drug profiles in the detailed report…..
19. Inactive Products
20. Obstructive Sleep Apnea Key Companies
21. Obstructive Sleep Apnea Key Products
22. Obstructive Sleep Apnea- Unmet Needs
23. Obstructive Sleep Apnea- Market Drivers and Barriers
24. Obstructive Sleep Apnea- Future Perspectives and Conclusion
25. Obstructive Sleep Apnea Analyst Views
26. Obstructive Sleep Apnea Key Companies
27. Appendix

List of Top Selling Market Research Reports in 2024

cardiac monitoring devices market- https://www.delveinsight.com/report-store/cardiac-monitoring-devices-market
embolotherapy market- https://www.delveinsight.com/report-store/embolotherapy-market
keloid market- https://www.delveinsight.com/report-store/keloid-market
orthopedic power devices market- https://www.delveinsight.com/report-store/orthopedic-power-devices-market
shingles market- https://www.delveinsight.com/report-store/shingles-market
short bowel syndrome market- https://www.delveinsight.com/report-store/short-bowel-syndrome-market
surgical sealant market- https://www.delveinsight.com/report-store/surgical-sealant-and-adhesives-market
testicular neoplasm market- https://www.delveinsight.com/report-store/testicular-cancer-market
dyspepsia market- https://www.delveinsight.com/report-store/dyspepsia-market
liquid biospy for cancer diagnostics market- https://www.delveinsight.com/report-store/liquid-biopsy-in-cancer-diagnostics-market
perennial allergic rhinitis market- https://www.delveinsight.com/report-store/perennial-allergic-rhinitis-market
plaque psoriasis market- https://www.delveinsight.com/report-store/chronic-plaque-psoriasis-market
polycystic ovarian syndrome market- https://www.delveinsight.com/report-store/polycystic-ovarian-syndrome-market
respiratory syncytial virus market- https://www.delveinsight.com/report-store/respiratory-syncytial-virus-rsv-market
sarcopenia market- https://www.delveinsight.com/report-store/sarcopenia-market
smoking cessation and nicotine addiction market- https://www.delveinsight.com/report-store/smoking-cessation-and-nicotine-addiction-market
vascular grafts market- https://www.delveinsight.com/report-store/vascular-grafts-market
brucellosis market- https://www.delveinsight.com/report-store/brucellosis-market
catheter stabilization devices market- https://www.delveinsight.com/report-store/catheter-stabilization-securement-device-market
gene therapy in cns disorder market- https://www.delveinsight.com/report-store/gene-therapy-in-cns-disorder-market
nonalcoholic steatohepatitis market- https://www.delveinsight.com/blog/nonalcoholic-steatohepatitis-nash-highly-epidemic
pelvic organ prolapse market- https://www.delveinsight.com/report-store/pelvic-organ-prolapse-market
pertussis market- https://www.delveinsight.com/report-store/pertussis-market
sglt2 inhibitors market- https://www.delveinsight.com/report-store/sglt2-inhibitors-market
viscosupplementation devices market- https://www.delveinsight.com/report-store/viscosupplementation-devices-market
bacterial meningitis market- https://www.delveinsight.com/report-store/meningococcal-meningitis-market
carcinoid syndrome market- https://www.delveinsight.com/report-store/carcinoid-tumor-market
cxcr inhibitors market- https://www.delveinsight.com/report-store/selective-inhibitor-of-the-cxcr4-chemokine-receptor-market-forecast
endoscopic ultrasound market- https://www.delveinsight.com/report-store/endoscopic-ultrasound-market
hdac inhibitors market- https://www.delveinsight.com/report-store/hdac-inhibitors-market
myeloproliferative neoplasms market- https://www.delveinsight.com/report-store/myeloproliferative-neoplasms-market
plasmodium vivax malaria market- https://www.delveinsight.com/report-store/plasmodium-vivax-malaria-market
vascular access devices market- https://www.delveinsight.com/report-store/vascular-access-device-market
venous ulcer market- https://www.delveinsight.com/report-store/venous-leg-ulcer-market
ventral hernia market- https://www.delveinsight.com/report-store/hernia-repair-devices-market
vitreoretinal surgery devices market- https://www.delveinsight.com/report-store/vitreoretinal-surgery-devices-market
wound healing devices market- https://www.delveinsight.com/report-store/wound-healing-devices-market
novel drug delivery devices market- https://www.delveinsight.com/report-store/novel-drug-delivery-devices
phototherapies for psoriasis market- https://www.delveinsight.com/report-store/phototherapies-for-psoriasis-market
pulmonary emphysema market- https://www.delveinsight.com/report-store/chronic-obstructive-pulmonary-disease-copd-market
urea cycle disorders market- https://www.delveinsight.com/blog/urea-cycle-disorder-market
overactive bladder syndrome market- https://www.delveinsight.com/report-store/overactive-bladder-market
pipeline assessment services- https://www.delveinsight.com/consulting/pipeline-assessment-services
somatotropin deficiency market- https://www.delveinsight.com/report-store/somatotropin-deficiency-market
thrombectomy devices market- https://www.delveinsight.com/report-store/thrombectomy-devices-market
tourette syndrome market- https://www.delveinsight.com/report-store/tourette-syndrome-market
external defibrillators market- https://www.delveinsight.com/report-store/defibrillator-market
plantar fasciitis market- https://www.delveinsight.com/report-store/plantar-fasciitis-market
scoliosis market- https://www.delveinsight.com/report-store/scoliosis-market
tendonitis market- https://www.delveinsight.com/report-store/tendonitis-market
urinary catheters market- https://www.delveinsight.com/report-store/urinary-catheters-market
lice infestations market- https://www.delveinsight.com/report-store/lice-infestations-market
peripheral nerve injuries market- https://www.delveinsight.com/report-store/peripheral-nerve-repair-devices-market
sepsis market- https://www.delveinsight.com/report-store/sepsis-market
stem cell market- https://www.delveinsight.com/report-store/stem-cell-market
varicose vein treatment devices market- https://www.delveinsight.com/report-store/varicose-vein-treatment-devices-market
chronic neuropathic pain market- https://www.delveinsight.com/report-store/chronic-neuropathic-pain-market
fabry disease market- https://www.delveinsight.com/report-store/fabry-disease-market
consulting solutions- https://www.delveinsight.com/consulting
pacemakers market- https://www.delveinsight.com/report-store/pacemakers-market
positive airway pressure device market- https://www.delveinsight.com/report-store/positive-airway-pressure-device-market
spinal implants market- https://www.delveinsight.com/report-store/spinal-implants-market
transcatheter heart valve replacement devices market- https://www.delveinsight.com/report-store/transcatheter-heart-valve-replacement-devices-market
lymphoedema market- https://www.delveinsight.com/report-store/lymphedema-market
seltorexant drug market- https://www.delveinsight.com/report-store/major-depressive-disorder-market
surgical mask & respirator market- https://www.delveinsight.com/report-store/surgical-mask-respirator-market
meningococcal meningitis market- https://www.delveinsight.com/report-store/meningococcal-meningitis-market
surgical energy instruments market- https://www.delveinsight.com/report-store/surgical-energy-instruments-electrosurgical-devices-market
surgical lasers market- https://www.delveinsight.com/report-store/surgical-lasers-market
TCR therapy market- https://www.delveinsight.com/report-store/t-cell-receptor-tcr-therapy-market
diabetic wound market- https://www.delveinsight.com/report-store/diabetic-foot-ulcers-dfus-market
indwelling catheters market- https://www.delveinsight.com/report-store/indwelling-catheters-market
Nontuberculous Mycobacterial Market- https://www.delveinsight.com/report-store/nontuberculous-mycobacterial-ntm-infections-market
intraocular lens market https://www.delveinsight.com/report-store/intraocular-lens-market
orthopedic splints device market- https://www.delveinsight.com/report-store/orthotic-devices-market
transcatheter treatment market- https://www.delveinsight.com/report-store/transcatheter-heart-valve-replacement-devices-market
antibody drug conjugate market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-market
bone growth stimulator market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
NK cell therapy market- https://www.delveinsight.com/report-store/nk-cell-therapy-market
competitive benchmarking- https://www.delveinsight.com/consulting/competitive-benchmarking-services
total knee arthroplasty market- https://www.delveinsight.com/report-store/total-knee-arthroplasty-market
microscopy device market- https://www.delveinsight.com/report-store/microscopy-device-market
skin neoplasm market- https://www.delveinsight.com/blog/skin-cancer-treatment-market-and-key-companies
asperger syndrome market- https://www.delveinsight.com/report-store/autism-spectrum-disorder-asd-market

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Phone: 09650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

This release was published on openPR.